Regeneus Ltd banks $2.4 million research and development tax incentive

The biotechnology company is focused on its R&D program and is funded with a $1.9 million R&D loan from Paddington Street Finance Pty Ltd.

Regeneus Ltd (ASX:RGS) has received a $2.4 million in cash from the Australian Government’s research and development (R&D) tax incentive program for work it undertook during the 2017-18 financial year.

The clinical-stage regenerative medicine company reported its eligible R&D spending in the 2018 financial year was in line with what it spent in the 2016-17 period.

Read more